Status:
COMPLETED
Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!
Lead Sponsor:
Ahmed Saad
Conditions:
PCOS (Polycystic Ovary Syndrome)
Eligibility:
FEMALE
20-38 years
Phase:
PHASE1
PHASE2
Brief Summary
The goal of this clinical trial is to learn if drospirenone can work to prevent LH surge in controlled ovarian stimulation in PCOS cases undergoing ART cycles. The main questions it aims to answer are...
Detailed Description
The goal of this novel clinical trial is to study if drospirenone can work to prevent LH surge in controlled ovarian stimulation in PCOS cases undergoing ART cycles in comparison to a gold standard dr...
Eligibility Criteria
Inclusion
- PCOS was diagnosed according to the Rotterdam consensus criteria (two out of three of the following criteria):
- oligo- or anovulation
- clinical and/or biochemical signs of hyperandrogenism
- polycystic ovaries).
- A diagnosis of congenital adrenal hyperplasia, Cushing's syndrome, androgen-producing tumours, hyperprolactinemia and thyroid dysfunction were all rulled out.
Exclusion
- age 38 years
- basal FSH level 12 mIU/mL
- previous ovarian surgery
- congenital uterine anomaly anomaly, intrauterine adhesion and male partner with non-obstructive azoospermia.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06608186
Start Date
October 1 2024
End Date
January 19 2025
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hawaa Fertility center
Banhā, Qalyubia Governorate, Egypt, 13512